Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 173.07 USD 0.49%
Market Cap: 10.4B USD

Intrinsic Value

The intrinsic value of one ASND stock under the Base Case scenario is 210.45 USD. Compared to the current market price of 173.07 USD, Ascendis Pharma A/S is Undervalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ASND Intrinsic Value
210.45 USD
Undervaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ascendis Pharma A/S

Valuation History Unavailable

Historical valuation for ASND cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare ASND to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ASND?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Ascendis Pharma A/S
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ascendis Pharma A/S

Current Assets 921.5m
Cash & Short-Term Investments 517.9m
Receivables 76.8m
Other Current Assets 326.7m
Non-Current Assets 140m
Long-Term Investments 40.9m
PP&E 92.4m
Intangibles 3.9m
Other Non-Current Assets 2.7m
Efficiency

Free Cash Flow Analysis
Ascendis Pharma A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ascendis Pharma A/S

Revenue
368.7m EUR
Cost of Revenue
-54.2m EUR
Gross Profit
314.5m EUR
Operating Expenses
-640.8m EUR
Operating Income
-326.3m EUR
Other Expenses
-15.4m EUR
Net Income
-341.7m EUR
Fundamental Scores

ASND Profitability Score
Profitability Due Diligence

Ascendis Pharma A/S's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

49/100
Profitability
Score

Ascendis Pharma A/S's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

ASND Solvency Score
Solvency Due Diligence

Ascendis Pharma A/S's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
36/100
Solvency
Score

Ascendis Pharma A/S's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ASND Price Targets Summary
Ascendis Pharma A/S

Wall Street analysts forecast ASND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASND is 228.23 USD with a low forecast of 195.94 USD and a high forecast of 303.45 USD.

Lowest
Price Target
195.94 USD
13% Upside
Average
Price Target
228.23 USD
32% Upside
Highest
Price Target
303.45 USD
75% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Ascendis Pharma A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for ASND is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ASND stock?

The intrinsic value of one ASND stock under the Base Case scenario is 210.45 USD.

Is ASND stock undervalued or overvalued?

Compared to the current market price of 173.07 USD, Ascendis Pharma A/S is Undervalued by 18%.

Back to Top